Finegoldia magna: a forgotten pathogen in prosthetic joint infection rediscovered by molecular biology

Pierre-Yves Levy1, Florence Fenollar, Andreas Stein

  • 1Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes-Unité Mixte de Recherche, Centre National de la Recherche Scientifique 6236-Institut de Recherche et Developpement 198, Faculté de Médecine, Université de la Méditerranée, Marseille, France.

Insights

Finegoldia magna causes prosthetic infections in 2% of cases, often with polymicrobial or nosocomial infections. Current antibiotic prophylaxis shows limited effectiveness against this bacterium, highlighting diagnostic and treatment challenges.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Orthopedic Surgery

Background:

  • Prosthetic joint infections are a significant clinical challenge.
  • Finegoldia magna is an emerging pathogen in orthopedic infections.
  • Understanding F. magna's role is crucial for effective management.

Purpose of the Study:

  • To report on a series of patients with prosthetic infections caused by Finegoldia magna.
  • To highlight the diagnostic and therapeutic challenges associated with F. magna infections.
  • To assess the prevalence of F. magna in prosthetic infections.

Main Methods:

  • Retrospective case series analysis of 13 patients.
  • Identification of F. magna using molecular diagnostic techniques.
  • Review of patient presentation and treatment outcomes.

Main Results:

  • Finegoldia magna was identified in 13 patients (2% of the series).
  • Infections were associated with open fractures or nosocomial prosthesis implantation.
  • Standard antibiotic prophylaxis demonstrated poor activity against F. magna.

Conclusions:

  • Finegoldia magna is a relevant cause of prosthetic infections.
  • Molecular diagnostics are essential for accurate F. magna identification.
  • Current prophylactic antibiotics are inadequate against F. magna, necessitating revised treatment strategies.

Related Concept Videos

History of Microbiology01:28

History of Microbiology

Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...